Abstract: A system includes processing circuitry and a drone. The drone includes a dispenser subassembly that includes a housing comprising an aerosol dispensing system and configured to receive a syringe such that an applicator of the syringe is positioned distally from the housing; a trigger that is positioned in contact with a nozzle of the aerosol dispensing system; an actuator arm; and an actuator motor configured to move the actuator arm in a reciprocating motion. Control logic of the drone is configured to navigate, based on navigation instructions received from the processing circuitry, the drone to an area associated with an object of potential survey interest (OoPSI) such that the applicator of the syringe or the nozzle of the aerosol dispensing system is proximate to the area associated with the OoPSI.

Abstract: The invention provides a method allowing to determine whether a subject diagnosed with cancer is sensitive or resistant to an anti-cancer treatment, based on the level of cells with RAD51 foci in a sample containing tumor cells isolated from said subject, wherein the subject has not received at 24 hours prior to the isolation of the sample, a chemotherapy selected from the group consisting of AC, FEC, ECF and navelbine/epirubicin, and wherein the sample has not been treated with a method that induces DNA damage before determining the level of cells with RAD51 foci.

Abstract: A system includes an algae bioreactor that contains an algae slurry, a heat exchanger in fluid communication with the algae bioreactor to receive the algae slurry from the algae bioreactor and heat and increase a pressure of the algae slurry, and one or more valves and a flash vessel in fluid communication with a discharge of the heat exchanger to flash the algae slurry and create steam and algae biomass. A separator receives the algae biomass from the flash vessel and separates oils from the algae biomass to generate a biofuel.

Abstract: An apparatuses relating generally to a test wafer, processing chambers, and method relating generally to monitoring or calibrating a processing chamber, are described. In one such an apparatus for a test wafer, there is a platform. An optical fiber with Fiber Bragg Grating sensors is located over the platform. A layer of material is located over the platform and over the optical fiber.

Abstract: Systems and/or methods for producing free elements, systems and/or methods for producing element storage/generation vessel assemblies, element storage/generation vessel assemblies, system and/or methods for purifying elements and providing a progeny generating assemblies are provided.

Abstract: Systems and methods are provided for performing ammonia cracking as the endothermic reaction step of a reaction cycle in a cyclic reaction environment, such as a reverse flow reaction environment. In such aspects, heat for the endothermic reaction can be provided by direct heating during a regeneration step. Optionally, the fuel for the regeneration step can correspond to additional ammonia and/or can include hydrogen generated during the ammonia cracking reaction step. Optionally, a selective catalytic reduction (SCR) zone can be included as part of the reactor, to reduce or minimize the amount of nitrogen oxides in the regeneration effluent from the reactor.

Abstract: The invention provides compositions and methods for use in the treatment and prevention of cholestatic diseases.

Abstract: A laminate including: a first ply having a first surface and a second surface, where the first surface is an outer surface of the laminate; a second ply having a third surface facing the second surface and a fourth surface opposite the third surface, where the fourth surface is an inner surface of the laminate; an interlayer between the plies; and an enhanced p-polarized reflective coating positioned over at least a portion of a surface of the plies. When the laminate is contacted with radiation having p-polarized radiation at an angle of 60° relative to normal of the laminate, the laminate exhibits a LTA of at least 70% and a reflectivity of the p-polarized radiation of at least 10%. A display system and method of projecting an image in a heads-up display is also disclosed.

Abstract: Devices, systems and methods are provided for treating of target tissue within a body of a patient, particularly tumors. Such systems can include an energy delivery device having at least one energy delivery body configured to be positioned near a target tissue area of the patient, and a generator in electrical communication with the at least one energy body. The generator can include at least one energy delivery algorithm configured to provide an electric signal of pulsed electric field energy deliverable to the at least one energy delivery body so as to induce extravasation within the target tissue area.

Abstract: An adjustable collimator includes pairs of knobs configured to adjust an aperture size by manipulating one or both of the knobs. A pair of knobs configured to adjust different dimensions of the aperture may be disposed at opposite sides of the collimator. Another pair of knobs configured to adjust different dimensions of the aperture may be disposed on a same side of the collimator.

Abstract: An architectural transparency includes a substrate; a first dielectric layer over at least a portion of the substrate, a first metallic layer over the first dielectric layer, a first primer layer over the first metallic layer, a second dielectric layer over the first primer layer, a second metallic layer over the second dielectric layer, a second primer layer over the second metallic layer, a third dielectric layer over the second primer layer, a third metallic layer over the third dielectric layer, a third primer layer over the third dielectric layer, and a fourth dielectric layer over the third primer layer. At least one of the metallic layers is a subcritical metallic layer.

Abstract: A test and measurement device includes an input port for receiving a bus conducting data from a device under test, and processing element coupled to the input port. The processing element is configured to execute instructions that cause the processing element to determine a data sequence from a signal of the bus received on a main channel of the device, and use information from at least one other signal of the bus on an auxiliary channel of the device based upon a protocol associated with the bus to adjust parameters for performing error detection on the data sequence.

Abstract: A method includes: transmitting, by a first radio frequency transceiver of a first device, a first signal; receiving, by the first radio frequency transceiver of the first device, a second signal in response to the first signal; determining a time value associated with the receiving of the second signal; determining that at least one of the time value or a distance value determined using the time value is less than or equal to a first threshold value, wherein the first threshold value is associated with the first device; and triggering a first output by a user interface component of the first device based on at least one of the time value or the distance value being less than or equal to the first threshold value.

Abstract: Imaging devices, systems, and methods for determining a distance to an object using light projected from an illumination device are provided. An example method includes: projecting, from an illumination source of the illumination device, projected light having a first wavelength; receiving, at one or more sensors of the illumination device, reflected light having the first wavelength; receiving, at the one or more sensors of the illumination device, emitted light having a second wavelength; determining, by one or more processors, a phase difference between the reflected light and the emitted light; and determining, by the one or more processors, the distance to the object based at least on the phase difference between the reflected light and the emitted light.

Abstract: A valve assembly for a fuel tank includes a cage having a seat that defines an aperture and a spring latch that holds a poppet in an intermediate-open position, which spaces the poppet from a seat to allow fluid communication through an aperture. A method of operating a valve assembly due to a first-time fueling event is disclosed.

Abstract: The disclosed technology generally relates to integrated circuit devices with wear out monitoring capability. An integrated circuit device includes a wear-out monitor device configured to record an indication of wear-out of a core circuit separated from the wear-out monitor device, wherein the indication is associated with localized diffusion of a diffusant within the wear-out monitor device in response to a wear-out stress that causes the wear-out of the core circuit.

Abstract: Methods, systems, and apparatus, including computer programs encoded on computer storage media, for training and deploying machine-learned communication over RF channels. In some implementations, information is obtained. An encoder network is used to process the information and generate a first RF signal. The first RF signal is transmitted through a first channel. A second RF signal is determined that represents the first RF signal having been altered by transmission through the first channel. Transmission of the first RF signal is simulated over a second channel implementing a machine-learning network, the second channel representing a model of the first channel. A simulated RF signal that represents the first RF signal having been altered by simulated transmission through the second channel is determined. A measure of distance between the second RF signal and the simulated RF signal is calculated. The machine-learning network is updated using the measure of distance.

Abstract: The invention provides formulations for oral delivery of a therapeutic agent wherein the formulation comprises a kappa opioid receptor agonist, an oligosaccharide stabilizing agent and an optional absorption enhancer. The kappa opioid receptor agonist may be coated with, embedded in or mixed with an oligosaccharide, such as trehalose. Also provided are capsules containing the oral formulations of the kappa opioid receptor agonists, the oligosaccharide and the absorption enhancer of the invention. The invention further provides methods of manufacture of the formulations and methods of their use for the prophylaxis, inhibition and treatment of variety of kappa opioid receptor-associated diseases and conditions such as pain, pruritus and inflammation. The methods of use include administering to the mammal the formulation of the kappa opioid receptor agonist, oligosaccharide and optional absorption enhancers.